Paper36975452
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options.
Petrella F and 10 others. Curr Oncol, 2023. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options. Papers, record 36975452. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36975452
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Humans | |
| Neoplasm Staging | |
| Combined Modality Therapy | |
| Neoadjuvant Therapy |
Source PubMed
References119
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34295668 | International consensus on severe lung cancer-the first edition. | Transl Lung Cancer Res | 2021 | https://conductscience.org/library/papers/34295668 | PubMed |
| 2 | 33993258 | Veno-venous extra-corporeal membrane oxygenation-assisted right tracheal-sleeve pneumonectomy. | Interact Cardiovasc Thorac Surg | 2021 | https://conductscience.org/library/papers/33993258 | PubMed |
| 3 | 33689449 | Improving Care for Patients With Stage III or IV NSCLC: Learnings for Multidisciplinary Teams From the ACCC National Quality Survey. | JCO Oncol Pract | 2021 | https://conductscience.org/library/papers/33689449 | PubMed |
| 4 | 34165501 | Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/34165501 | PubMed |
| 5 | 22124104 | Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22124104 | PubMed |
| 6 | 28823336 | Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer. | Semin Thorac Cardiovasc Surg | 2017 | https://conductscience.org/library/papers/28823336 | PubMed |
| 7 | 4170866 | The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. | Radiology | 1968 | https://conductscience.org/library/papers/4170866 | PubMed |
| 8 | 28885881 | Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28885881 | PubMed |
| 9 | 28153512 | Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells. | Biomed Pharmacother | 2017 | https://conductscience.org/library/papers/28153512 | PubMed |
| 10 | 16434292 | Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: preliminary results. | J Thorac Cardiovasc Surg | 2006 | https://conductscience.org/library/papers/16434292 | PubMed |
| 11 | 11071672 | A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. | N Engl J Med | 2000 | https://conductscience.org/library/papers/11071672 | PubMed |
| 12 | 3032394 | Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. | Cancer | 1987 | https://conductscience.org/library/papers/3032394 | PubMed |
| 13 | 28717413 | Revisions to the Tumor, Node, Metastasis staging of lung cancer (8th edition): Rationale, radiologic findings and clinical implications. | World J Radiol | 2017 | https://conductscience.org/library/papers/28717413 | PubMed |
| 14 | 17235046 | Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17235046 | PubMed |
| 15 | 33668021 | NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. | J Natl Compr Canc Netw | 2021 | https://conductscience.org/library/papers/33668021 | PubMed |
| 16 | 12177106 | Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/12177106 | PubMed |
| 17 | 29338734 | Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis. | World J Surg Oncol | 2018 | https://conductscience.org/library/papers/29338734 | PubMed |
| 18 | 16040924 | Metallic prosthesis: technique to avoid increase in CT radiation dose with automatic tube current modulation in a phantom and patients. | Radiology | 2005 | https://conductscience.org/library/papers/16040924 | PubMed |
| 19 | 34383006 | Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/34383006 | PubMed |
| 20 | 29405289 | Role of artificial intelligence in the care of patients with nonsmall cell lung cancer. | Eur J Clin Invest | 2018 | https://conductscience.org/library/papers/29405289 | PubMed |
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42981048 | Gramicidin Inhibits Lung Cancer Metastasis by Suppressing the ABL-MMP9 Signaling Axis. | J Biochem Mol Toxicol | 2026 | https://conductscience.org/library/papers/42981048 | PubMed |
| 42879405 | Predicting lymph node metastasis in non-small cell lung cancer using clinical and PET/CT-derived morphological features: An interpretable machine-learning study. | PLoS One | 2026 | https://conductscience.org/library/papers/42879405 | PubMed |
| 42720907 | MYBL2 promotes malignant phenotypes and M2-like macrophage polarization through CCL2 in non-small cell lung cancer. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42720907 | PubMed |
| 42675106 | Machine learning-based mapping of multimodal treatment allocations and prognostic implications of clinical concordance in non-small cell lung cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/42675106 | PubMed |
| 42630367 | Alterations in peripheral blood inflammatory mediators, vascular endothelial growth factor, and serum tumor markers in advanced non-small cell lung cancer patients treated with bevacizumab combined with chemotherapy. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42630367 | PubMed |
| 42610673 | Multidisciplinary Team Care for Early-Stage Lung Cancer in Low- and Middle-Income Countries and Emerging Economies: Current Position and Call for Action. | Thorac Cancer | 2026 | https://conductscience.org/library/papers/42610673 | PubMed |
| 42583046 | Immune-preserving radiotherapy and perioperative immunotherapy in stage III NSCLC: a narrative review of current management and future directions for IIIA/IIIB NSCLC. | Transl Lung Cancer Res | 2026 | https://conductscience.org/library/papers/42583046 | PubMed |
| 42562962 | Lactate derived from CAFs mediates H3K18la in stemness gene promoters, which promotes tumor malignant phenotype formation. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/42562962 | PubMed |
| 42558266 | Redefining the concept of resectability in the landscape of perioperative treatments for lung cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42558266 | PubMed |
| 42530845 | Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42530845 | PubMed |
| 42529140 | RATIONALE-303: Long-Term Outcomes of Tislelizumab in Previously Treated Advanced/Metastatic NSCLC. | JTO Clin Res Rep | 2026 | https://conductscience.org/library/papers/42529140 | PubMed |
| 42453889 | Effectiveness and safety of carbon ion radiotherapy for stage III non-small cell lung cancer: a single-center retrospective study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42453889 | PubMed |
| 42449581 | Efficacy and Time-Dependent Pattern of Consolidation Immunotherapy in Stage III Non-Small Cell Lung Cancer After Induction Chemoimmunotherapy and Radiotherapy: A Dual-Center Retrospective Cohort Study. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449581 | PubMed |
| 42421998 | Upfront Surgery for c-Stage IIIB Non-Small Cell Lung Cancer with an Abnormally High Preoperative Serum Carcinoembryonic Antigen Level: A Case Report. | Surg Case Rep | 2026 | https://conductscience.org/library/papers/42421998 | PubMed |
| 42360010 | Exploring the Therapeutic Potential of Nobiletin in Nonsmall Cell Lung Cancer. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42360010 | PubMed |
| 42306763 | Tumor stage, squamous histology and male sex predict positive resection margins in non-small cell lung cancer patients undergoing anatomical resection-a retrospective study from a high-volume thoracic surgery unit. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42306763 | PubMed |
| 42236985 | Debate: why surgery should remain central in the management of locally advanced (Stage III) non-small-cell lung cancer. | BJC Rep | 2026 | https://conductscience.org/library/papers/42236985 | PubMed |
| 42180050 | Leveraging CT-based online adaptive radiotherapy for dose escalation in hypofractionated radiotherapy for locally advanced unresectable lung cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42180050 | PubMed |
| 42129521 | Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42129521 | PubMed |
| 42074140 | Epithelial Integrins Coordinate Cellular Crosstalk Through the Regulation of Cytokines During Tissue Remodeling. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074140 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| ROS1 | 6098 | PubTator's text mining | https://conductscience.org/library/genes/6098 | NCBI Gene |
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36975452
GET https://conductscience.org/api/papers/v1/36975452/references?page=2